Certificate u/r 74(5) for the quarter ended 31/12/2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samrat Pharmachem has submitted a quarterly compliance certificate from its Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited, under SEBI Regulation 74(5) for the October–December 2025 quarter. The RTA has confirmed that all share certificates received from depository participants for dematerialisation during the quarter were properly verified, accepted or rejected, and the corresponding physical certificates were mutilated and cancelled. The names of the depositories have been updated as the registered owners in the company's shareholder register within the timelines required by SEBI.
This is a routine regulatory compliance filing with no material impact on the business, financials, or share price. It only confirms that share dematerialisation requests were processed normally during the quarter.